Meduna introduced convulsion therapy as the treatment of certain mental disorders. The convulsions he initiated with what, from a clinical viewpoint, were overdoses of analeptic agents-par excellence, cardiazol.
Two disadvantages of this technique rapidly became apparent. Firstly, that the violence, and perhaps nature, of these convulsions was in many instances sufficient to produce crush injuries and dislocations, especially of the spine, and, secondly, that the prodromal stage of the convulsion was. so unpleasant that an appreciable number of patients refused to continue treatment. Thus we find that, from the late 1930's onwards, attempts were being made (a) to attenuate the violence of the convulsions (Bennett, 1940 , 1941 , 1943 , and Palmer's 1939 , 1946 to anesthetize the patient before and through the induction of the convulsion.
In 1938 Cerletti and Bini induced convulsions electrically, and the instantaneous stunning effect of this method, together with the associated retrograde amnesia, obviated almost entirely the (to the patient) major conscious objection to the older technique, i.e. its well-remembered unpleasantness.
The objective complications of fracture and dislocation remained, but though the likelihood was accepted as a possibility, the percentage of incidence was so little agreed upon-as the figures in several papers show-that the majority of workers relied on posture and restraint to keep these in check.
It was in 1947 that, consequent on its widespread availability, Hobson and Prescott reported their use of curare in electric convulsion therapy.
Papers on the use of decamethonium iodide (C 10) and gallamine (Flaxedil) followed and two schools of thought were soon apparent: (1) Those who did attenuate, using either tubocurarine, gallamine or C 10 with or without a cover of thiopentone, and (2) Those who regarded attenuation as unnecessary and maybe hazardous.
In 1949 Bovet et al. drew attention to the paralysant action of the bis-choline esters of succinic acid. He claimed that in animals, these produced paralysis of short duration with an ultra-rapid onset and an equally rapid recession. It is on the use of these during the past year that this paper is based.
The physiologically active (or paralysing) part of the molecule is the cation, a chain at each end of which is a quatemary ammonium group.
These ammonium groups are of two kinds: they may contain 3 methyl (CHs) groups and are then called methonium, or one of these methyl groups may be substituted by an ethyl (C2H6) group and then the term ethonium is used. Thus the whole active cation (bearing in mind that the acid is succinic} may be called suxamethonium or suxethonium.
DEc.-PSYCHIAT. AND!ANEsTH.w1 Tubocurarine and gallamine both paralyse by what is called "a curarizing action", in contradistinction to decamethonium iodide (C 10), and these new short-acting relaxants which exert their influence by depolarization.
The train of events leading to a normal contraction of a muscle fibre is that a nerve impulse passes down the nerve until it reaches the motor end-plate. In response to its arrival, acetylcholine is released. This is attracted to, and acts on, receptors lying at the muscle membrane, effecting a change of potential, and this depolarization initiates the contraction of the muscle fibre. The curarizing agents, curare and gallamine, act by saturating the receptors at the muscle membrane and rendering them unavailable to acetylcholine. That is, acetylcholine goes on being produced and goes on being destroyed normally. The muscle fibre remains normal and sensitive to acetylcholine. It is merely that the acetylcholine cannot reach it to set off the reaction. The pistol is loaded, but the trigger cannot be pulled.
If, now, Prostigmin is given, the cholinesterase, which is destroying the acetylcholine, is inactivated. Acetylcholine therefore builds up to a concentration high enough in the end to overcome the block presented by the curare: the muscle contracts.
C 10 and the short-acting relaxants, on the other hand, behave rather like a large and prolonged dose of acetylcholine itself, by depolarizing first the muscle membrane, which is what acetylcholine does (and of this, of course, the fibrillary twitching which occurs just after the injection is a sign), and then a narrow zone of underlying muscle tissue. They paralyse because the acetylcholine, which is being normally produced and can reach its receptors unimpeded, finds the membrane already depolarized, and no longer electrically excitable. The trigger can be pulled, but the pistol is not primed. Prostigmin is to be discouraged as an antidote, as the paralysis may be indefinitely prolonged by it.
Several points arise from a consideration of the clinical usage of the drug, which as Dr. Scurr reported (1951) we commenced using last year for the attenuation of ECT.
Firstly, none of our patients was premedicated with atropine. I have always hesitated to submit any candidate for a minor medical manceuvre (especially an out-patient) to the added (and so often unnecessary) discomfort of a dry mouth, and with these short-acting relaxants especially, the protective mechanisms of swallowing and coughing return to full vigour with such rapidity that I think it is even less justified.
The other point arises from a personal experience of the drug and concerns the provision of adequate thiopentone "cover" for the relaxant.
In the very early stage of our work on these drugs, we gave a "sleep dose" of thiopentone and followed this with the relaxant, but before long we ventured to mix them in the same syringe and no impairment of activity being apparent, this technique we adopted for the next month or two.
Then, to study and record, without the complication of the ECT, the effect of this mixed dose of thiopentone and the drug we were giving, I myself had 3 c.c. of thiopentone mixed with 75 mg. gross weight of I.S. 362 (that is, 42 mg. of the active ethyl cation), a dose which we now know is inadequate for full paralysis.
I wrote this account immediately afterwards. "Scurr said he had injected; I would not have known this, though I felt the venepuncture, and kniew he had withdrawn blood.
"A consciousness of smell followed-not the classical smell of onions, but rather the hard clean smell of the chemistry laboratory. I commented on this I think with clarity. At this time, I had no feeling of anything unusual. However, a sensation of burning tightness followed around the neck and up the back of the head, and I knew I was becoming rapidly paralysed and this I said in a voice which I realized was very slurred.
"I was now in darkness and completely paralysed-although I attempted to move, I could do nothing.
"I still had some respiratory activity and I was aware of saliva in my pharynx. There was a slight catch in my respiration which I knew had a laryngeal origin and I thought 'Scurr will be worried by that'.
"Respiratory activity was now, I think, inadequate, and the proceedings could have developed a nightmare quality-darkness, suffocation and complete inability to move. "I heard Scurr say 'He's tough' and then, before panic set in, rather like coming out of a railway tunnel, I found that my respirations were deepening, my eyes opened and almost immediately I felt in full possession of all my power. There was no hangover-the feeling was very similar to the recovery from nitrous oxide. I had not been to sleep." My colour had remained normal throughout. I realized from this that in the dosage I was customarily giving, the relaxant acted quicker than the pentothal, which had, however, considerably dulled my appreciation of the unpleasantness, and, although I had not been to sleep, the experience had not been too alarming.
A week later, I had a dose of 75 mg. (gross weight) of I.S. 362 without any thiopentone.
Iindulled by barbiturate, I was painfully conscious of the real horror of the situation and the involuntary rapidity with which the residuum of my diaphragmatic power was exercised to maintain the maximum pulmonary ventilation possible was an index of the desperation felt.
This was a thoroughly unpleasant episode and to submit any patient to it is absolutely unjustifiable. Thereafter, I gave thiopentone first, normally 3 or 4 c.c. (150 or 200 mg.) and waited for the first deep sighing breath before injecting the relaxant from another syringe.
A few weeks ago, I once more decided to try on myself the effect of mixing the drugs, making certain this time that I went to sleep. We used 6 c.c. (300 mg.), of thiopentone and 55 mg. a.c. of Brevidd E and my account follows:
"Mask on face-quite comfortable-Scurr says 'Yes, that's fine' and I knew he had looked at the tracing. Prick on arm-no feeling in arm or shoulder and then a slow feeling of increasing warmth in back of neck and occiput-a feeling which simulated exactly the arborizing flame which one sometimes experiences on turning the head suddenly and which I attribute to nipping the roots of an occipital nerve. I thought rather grimly 'Here we go again' at which point the sensation faded and Scurr took the mask off. I said 'Carry on' (see Fig. 1 ). He replaced it but soon removed it again, and I realized that whatever had happened was over. I sat up and swung my legs over the side of the couch. Nurse made to hold me, but I said, 'No, no, let's see what I can do'. I stood unaided, buttoned the waistband of my trousers and turned round and unplugged the machine. About one minute later, I asked rather querulously who had stopped the machine."
DEC.-PSYCmAT. AND ANasTH. 2 I had, in fact, I realize now, gone to sleep almost as soon as I became conscious of the feeling of muscular stimulation and awakened calmly without realizing that I had lost consciousness, though nearly two minutes had elapsed. There was no sensation of paralysis or unpleasantness and though Dr. Scurr assures me that my twitchings and movements were considerable, I remember nothing of this. I am sure that the relaxant only raced the thiopentone by a few seconds, perhaps five, and now, assuming that one can rely on' most patients having at least five or ten seconds retrograde amnesia preceding the shock, I am mixing the drugs again and giving them from the same syringe, which of course is much more convenient. I give the injection as fast as possible as I think this assures the maximum depression from a minimum of thiopentone and, as the thiopentone hydrolyses the relaxant, it is essential to mix them at the last moment. I stress again with the utmost gravity the inadvisability of subjecting any patient to the terror of encroaching paralysis while conscious, a terror that the only patient we attempted it on remembered with distaste, despite the shock and convulsion.
Our routine technique now is to give, at the first treatment, 200 mg. of thiopentone mixed at the very last moment with 55 mg. a.c. of Brevidil E (equivalent to approximately 25 mg. a.c. or 30 mg. gross weight of Scoline), and thereafter to vary the dosage according to the phenomena observed.
This dosage of relaxant is for many people at the threshold of adequacy.
Injection is followed in about twenty seconds by closure of the eyes and a deep breath. This in turn is commonly followed by generalized fibrillary m,uscle twitching and other semi-co-ordinated movements, a picture very similar to that presented by a moderately well-attenuated convulsion. These widespread muscular flickerings represent the onset of depolarization and their subsidence indicates the onset of the maximum paralysis for that dose. The arms and hands are often lifted towards the neck and remain in half-flexion if so lifted, till they relax and drop into extension. This coincides with the end of the muscle twitching and is the signal for the shock to be given, and it almost always happens within twenty-five to thirty-five seconds after the injection. The convulsion is usually accompanied by the appearance of "gooseflesh" and at the end the reflexes are hyperactive and the plantar response is often extensor for a short while. Respiration commences almost immediately and reaches normal excursion in about one to two minutes. Some cases exhibited a transient slight cyanosis, but I found that oxygen was very rarely needed. For everyday practice, however, I would recommend the routine use of oxygen, and apparatus for its administration must always be to hand. In this context I would suggest that psychiatric departments employing relaxant agents should seek the advice of an experienced anasthetist on the apparatus and technique for insufflation with oxygen.
The average patient is well enough recoverec from unmodified ECT to be left untended within five to six minutes, and the actual convulsion rarely lasts more than a minute. Thus if attenuation is to be counted as a justifiable complication, full paralysis should last no longer than two minutes and should have completely receded within six. The short-acting relaxants fulfil these requirements. We have seen nothing to occasion alarm pr contra-indicate their use. Their advantages over C 10, gallamine, and tubarine, which cannot be pushed to ensure first-class attenuation without the certainty of residual curarization, are, I venture to suggest, obvious, and may be graphically demonstrated by spirometric tracings. The spirometer in each case was filled with oxygen, but there was no absorption of carbon dioxide. Thus the tracings represent the maximum respiratory activity of which these patients were capable. "P" indicates the injection of thiopentone and the relaxant in each case is marked. Each tracing shows the degree of attenuation of shock and convulsion by means of "plus" signs up to 3 for "very good". Fig. 1 is a tracing of the author (A. E.). "The points to note are that 55 mg. a.c. of Brevidil E were not a full paralysing dose and that two minutes after administration I was capable of a respiratory excursion of 3 litres. Fig. 2 shows four tracings from the same patient. "S" indicates the shock and "E" the end of the convulsion. The top tracing shows her respiratory pattern during the convulsion under thiopentone alone, that is, during a virtually unmodified convulsion. The scale to the right of this tracing, showing the extent of an excursion of 1,000 c.c., is valid for all the figures. The second tracing is her reaction under Brevidil E and here one may note that for her 55 mg. of active cation is a full and paralysing dose. It may be seen in the lower two tracings that dosages of Gallamine and C 10 which, did not produce perfect attenuation, yet resulted in prolonged respiratory depression; this markedly so in the case of C 10.
It is interesting that the tracing of the patient undergoing unmodified convulsion is very similar to the tracing of myself under the relaxant, yet in the patient the combination of convulsion and relaxant has resulted in a slightly delayed return of adequate respiratory activity. If an excess of acetylcholine is liberated during the convulsion as Hobson and Prescott (1947) suggested, this might to some extent potentiate the Brevidil and prolong its action for a few seconds. Fig. 3 demonstrates the danger of attempting perfect attenuation with the longer acting relaxants. In this case, the upper tracing shows the respiratory activity of a patient moderately attenuated with 60 mg. of gallamine. The increase to 80 mg. gave splendid attenuation, in every way comparable with that obtained using Brevidil. It also left us with a paralysed patient on our hands, whose behaviour agreed well with the figure of thirty minutes which Presland and Palmer (1950) gave as necessary for the recession of perfect ielaxation with gallamine. Fig. 4 (three tracings from another patient) shows that the methonium cation is approximately two and a half times as powerful as the ethonium. That is, 40 mg. of active methonium cation (as liberated by 60 mg. of Brevidil M or 50 mg. of Scoline) and 110 mg. of active ethonium cation (as liberated by 160 mg. of Brevidil E) produce a paralysis which, mirrored in respiratory activity, was identical in degree and duration.
These last tracings reflect the result of an intentional overdosage yet may be compared very favourably with overdosages of gallamine in Fig. 2 , and a scarcely adequate dosage (4 mg.) of C 10 in Fig. 1, and indeed, in no case have we seen apncea lasting longer than the three minutes mentioned by Woolley et al. (1942) as occurring occasionally after unmodified ECT.
Dr. Audrey L. Ferguson, Senior Registrar, Department of Psychological Medicine, Westminster Hospital: Since August 1951, we have used the newer short-acting muscle relaxants for the modification of ECT in co-operation with the Anesthetic Department of the Westminster Hospital. Prior to that date we had given either unmodified ECT, or where this was contra-indicated, ECT modified with either decamethonium iodide (C 10) or gallamine triethiodide (Flaxedil).
ECT either alone or modified with one of these longer-acting relaxants has two disadvantages. In the case of unmodified ECT, there is first the risk of bone injury, and second, the frequent development during treatment of a fear which makes the patient unwilling to continue the course. With regard to bone injury, Sargant and Slater (1948) noted that without newer methods of physical control 40% of patients sustained fractures, particularly compression fractures of vertebral bodies, and that this constituted the most frequent risk encountered in unmodified ECT. They recommend as a safeguard against such damage either the holding of the patient by five trained nurses or, alternatively, his insertion into a modified strait jacket before treatment: both these procedures are open to criticism. Cook (1944) quoted the incidence of crush fractures as 4% even under the best conditions and other writers report still higher figures. The unaccountable fear which develops in some patients during treatment is quite familiar to those who have given a number of ECTs and thiopentone has been employed by Cooper (1948) , Thorpe (1948) and many others to diminish this fear. For the same reason we ourselves as a routine used either thiopentone or sodium amytal intravenously in every unmodified case.
The principal disadvantages of using C 10 or Flaxedil to modify ECT are first, the uncertainty of producing perfect attenuation without considerable residual curarization, and second, the delay of from two to four minutes between the injection and the onset of maximal relaxation when the shock may be given.
The purpose of our investigation was to obtain sufficient data to compare the effectiveness of C 10 and Flaxedil with that of the newer short-acting group in the modification of ECT. As a secondary consideration we incorporated for comparison a number of cases who were given Ro 3-0386, i.e. 5: 6-Dithiadecane-l 10-bis (trimethylammonium iodide), and hereafter referred to as 30386.
The number of cases in whom this drug was used was limited by the small quantity available.
INVESTIGATION
The investigation was undertaken between August 1951 and May 1952; 37 cases received courses of ECT, making a total of 215 treatments in all. 30 of these treatments are excluded because of the unknown effect of subshocks and a further 8 for other reasons.
The remaining 177 treatments were as follows:
Unmodified ECT Each case which had either unmodified ECT, or ECT with a long-acting relaxant, also had a shortacting relaxant. In this way we ensured that any patients with peculiarly long recovery times did not only affect adversely the results in the unmodified or long-acting relaxant group.
The points we set out to investigate were:
(1) The patients' impressions of the treatments.
(2) The adequacy of the modification.
(3) The time of recovery of various functions.
RESULTS
Patients' impressions of treatments.-These were obtained by questioning each patient prior to every treatment about his recollections of the previous one. Unpleasantness prior to the administration of shock or during the recovery phase was noted.
Our first object was to discover whether the time of action of the new relaxants was so short that the amnesia resulting from ECI would be sufficient in itself to cover any known unpleasant effects of the drug, or if this were not so, whether the amount of thiopentone could be small relative to that required for the longer-acting relaxants. To this end we gave one man a set dose of 75 mg. I.S. 362 (the first of the new short-acting relaxants used by us) and reduced the dose of thiopentone accompanying it on successive occasions. As little as 50 mg. resulted in no complaints from the patient, so that with the fourth treatment we gave him no thiopentone at all. The next time he appeared very unwilling to continue the course and on questioning stated that he had felt himself unable to move, tried to fight against this sensation and had great difficulty in breathing. With return to the previous dose of thiopentone he was quite content thereafter. A second case was given 50 mg. of I.S. 362 and 150 mg. sodium amytal. She complained of feelings of suffocation and shaking all over as she went off to sleep. This latter appears to be related to the fibrillation of muscles prior to complete relaxation. As her convulsion was poorly attenuated with 50 mg. I.S. 362 we doubled the dose and gave her 150 mg. of thiopentone with it, but she again complained of similar unpleasant sensations although to a lesser degree than on the previous occasion. By increasing the thiopentone to 200 mg. we had no further complaints.
Following these preliminary trials we eventually established the average dose of each of the shortacting relaxants and found that an average accompaniment of 187 mg. of thiopentone was required to prevent the patient's having unpleasant feelings. One man to whom we gave almost twice the average dose of I.S. 362 complained of no actual respiratory difficulty, but of cold feelings and of fighting against something: these sensations did not arise when the thiopentone was increased beyond the average dose. Apart from these cases we had no other complaints in our series of 105 treatments modified by the short-acting relaxants despite the fact that in many instances the dose of thiopentone was well below average.
With the longer-acting relaxants we found that 30386 required an average adjuvant of 199 mg. of thiopentone, while with C 10 250 mg. and with Flaxedil 227 mg. were necessary, if complaints about treatment were to be avoided.
On the whole, we had few unfavourable comments from patients with any of the relaxants. Even with the longer acting C 10, 30386 and Flaxedil there were only single instances with each drug in which a patient complained of suffocation or vague fears when the accompanying thiopentone was given in dosages above the average for that particular relaxant. Two on 30386 complained with average doses of thiopentone. With those in whom thiopentone was below average we had no complaints in the 30386 series, two complaints with C 10 and two with Flaxedil.
In the Flaxedil series we had two or three patients who had severe headache and nausea or vomiting following treatment. Most interesting of all, however, was one patient who was able to pick out his Flaxedil treatments from those with Brevidil E, Brevidil M, C 10 and I.S. 362. He was given more than the average dose of thiopentone with less than.the average amount of Flaxedil, while the short-acting relaxants and their thiopentone were given only in average doses. In his distinction he said, referring to Flaxedil treatments: "I wake with a severe headache to find myself struggling and as if I want to climb up the walls." With the other drugs he said that he awoke feeling back to normal and could have got up at once, if required to do so; whereas after Flaxedil this would have been impossible. From the objective point of view his recovery after short-acting relaxants and C 10 was always quite smooth; after Flaxedil he fought and struggled with us for a considerable period of time before he could be moved into the recovery room. It is also of interest that with Flaxedil and C 10 modification of his convulsion was markedly less satisfactory than with the shortacting relaxants.
Adequacy of modification.-In order to determine our second point we considered both the attenuation of the initial jerk or "shock" and also that of the subsequent convulsion. To do so we laid down criteria similar to those already used by Davies and Lewis (1949) in their paper comparing C 10 and d-tubocurarine, which subdivided the modification of the convulsion into three degrees.
Our criteria were as follows: 
Modification of Convulsion
Movements of facial muscles including platysma. If any large joints were moving their movements required to be slight and with no power-no back movements were allowed. + + (Moderate) Large joint, facial and minimal back movements present. +
(Poor)
Marked back movements, though with some modification. No modification at all was scored if powerful back movements were present. These measurements were recorded in 98 treatments with the short-acting relaxant group, 16 with Flaxedil treatments, 18 with 30386, and 15 with C 10. In the short-acting group 52% of the patients obtained "good" modification for both the shock and convulsion at the same treatment, while with Flaxedil there were none, 28% with 30386, and 13% with C 10. It seems, therefore, that the new-relaxants act quickly enough to cover the period of shock and remain effective long enough to modify the convulsion. Fig. I illustrates the relative proportions of "good", "moderate" and "poor" results for shock and convulsion considered independently.
With regard to subshocks, we found there was always time to re-shock and still to obtain "good" or "moderate" attenuation. 2 of our cases were not re-shocked until 105 sec. following injection, but still showed triple + attenuation. The remainder of these cases showed that up to 70 sec. after injection one may be sure of "good" modification, but thereafter this degree of attenuation is more uncertain. Time of recovery of various functions.-The last assessment made was a comparison between the duration of the effects of (a) the short-acting relaxants, (b) unmodified ECT and (c) the longer-acting 30386, C 10 and Flaxedil.
Ideally, the important stages in the recovery phase would be when respiration had returned to a level where anoxia was no longer a danger; when the patient could safely be left unattended; and when he was fit to leave hospital. Since these stages are too indefinite for any accurate measurement, four points in the recovery phase were chosen as being relatively unambiguous in their times of occurrence and as giving a good indication of the duration of the drug's effects.
(1) Return of respiration: the first spontaneous breath.
(2) Return of muscular activity: the first movement of a part of the body as opposed to contraction of isolated muscle groups, e.g. turning of head or movement of toe or finger were accepted while blinking or rhythmic champing of jaws was rejected.
(3) Return of speech: Any intelligible response was accepted. During both this stage and the previous one, the patient was stimulated verbally but by no other means.
(4) Fitness to leave. The following criteria had to be fulfilled before fitness to leave was accepted: (a) The ability to stand and walk without any inco-ordination. (b) The ability to dress without assistance. (c) Correct orientation.
These times were recorded from the injection of the drug except in the case of unmodified ECT when of necessity they had to be taken from the induction of shock. The interval between injection and shock was kept relatively constant and at the optimal time for each drug. In order to make results comparable, the mean interval between injection and shock for the short-acting relaxants was added to all the unmodified ECT times.
The results for I.S. 362 and Brevidil E were closely alike in every way and the differences were of no significance. They were therefore combined for comparison with the longer-acting drugs. Fig. 2 shows these results in diagrammatic form. Except for the anomalous results in the times of fitness to leave which are discussed later, unmodified ECT showed the quickest recovery at all stages, as might be expected. The differences between these and the times for the short-acting group were small and analysis of the figures showed them to be of no great significance; while all the others showed greater differences which were in each instance highly significant. Since the shock was given much sooner after injection of the short-acting drugs than with the longer-acting ones, it seemed possible that we were measuring the time taken for recovery from the effects of ECT given at varying times after the injection, and not intervals attributable to the drug itself. When, however, the times were measured from induction of shock, the relationship between the short-acting group and unmodified ECT remained, of course, unaltered. With the other drugs the respiration times, while still being slightly greater than that of the shortacting group were no longer of any significance.
This suggests that return of respiration assessed by this method is dependent upon the apnoeic effect of the shock-little modified by the drug. Such a result was to be expected since respiration never entirely stopped prior to induction of shock except with the short-acting group. In the latter apncea was the rule and it is noteworthy that despite this there was no increased delay in the return of respiration. The differences for muscular activity and speech persisted, and, with the exception of speech in the case of 30386, remained significant though to a lesser degree. Another possible explanation for the differences lies in the slightly higher dose of thiopentone required with C 10 and Flaxedil,'but for practical purposes if it is necessary to give a larger dose of thiopentone it is of no great importance whether the delay is due to the relaxant or the thiopentone.
To give some idea of the extent to which this modifies recovery times, the coefficient of correlation between dosage of thiopentone and recovery of muscular activity was calculated in the I.S. 362 cases. This showed a positive correlation of 0-25 ± 0 056. When this figure was used for all results in the muscular activity group, it meant that the increased average dose of thiopentone contributed 8-4 secs. to 30386 times, 52 5 secs. to C 10 times and 35 secs. to Flaxedil times. The differences still remained but their significance became slightly less.
In the results for fitness to leave the recovery time for the short-acting group was significantly longer not only than unmodified ECT but also than 30386 and C 10. It was a little shorter than Flaxedil but not significantly so. This is both surprising and difficult to reconcile with consistently contrary results indicated by the return of muscular activity and speech.
Other observations made during the course of treatment lend support to the view that the result was due to some extraneous influence and not to the effect of the drug. Firstly, in many cases given 30386, C 10 or Flaxedil, there was noticeable curarization when speech returned while in the shortacting group, this was so in only one case when a considerable overdose of I.S. 362 was given. Secondly, the time at which patients were able to get up and walk with assistance was noticeably sooner with the short-acting group than with either C 10 or Flaxedil. This time was only measured in 8 of the short-acting group, when the mean was 9 min. With Flaxedil 4 cases showed a mean of 18 min., and 2 cases of C 10 a mean of 21 min. In their series Davies and Lewis stated that most cases of C 10 were able to walk with assistance 30 min. after treatment. Since the assessment of fitness to leave both presents difficulties in measurement and is open to innumerable unknown or little appreciated influences and since the time was decided by different members of staff it is possible that by then none of the drugs were exerting any influence iand the difference depended on variations in the interpretation or application of the criteria laid down. It is difficult to explain on this premise why the differences should be significant. But once the anomalous times became obvious this possibility was investigated. The criteria were re-emphasized, and great care was taken that they were uniformly applied. 43 cases were treated with short-acting relaxants, and the mean time for fitness to leave was 75-1 min., which showed no discrepancy from the series as a whole. The explanation therefore remained unknown, but the fact that the Flaxedil results showed a similar delay in fitness to leave is possibly significant, since they were obtained at a later date following the re-emphasis of the criteria. A further 6 cases of C 10 also done at this stage had a mean time for fitness to leave of 77-3 min., but the numbers were too small for any conclusions to be drawn.
CONCLUSIONS
(1) The short-acting relaxants are fully effective in a much shorter time than Flaxedil, C 10 or 30386, and the depression of respiration caused by them is of sufficiently brief duration to make oxygenation an exceptional rather than routine procedure.
(2) With the short-acting relaxant group in doses sufficient to produce adequate attenuation of both shock and convulsion, recovery to a point at which medical supervision is no longer necessary is quicker than with other relaxants.
(3) With all relaxants unpleasant effects can be avoided by giving an adequate dose of thiopentone, which dose is slightly smaller for the short-acting relaxants.
